NCT05585320 2025-09-02A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid TumorsImmuneering CorporationPhase 1/2 Active not recruiting209 enrolled
NCT06208124 2025-05-28A Study of IMM-6-415 in RAS/RAF Mutant Solid TumorsImmuneering CorporationPhase 1/2 Completed30 enrolled